Ken Griffin Vigil Neuroscience, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 2,165,811 shares of VIGL stock, worth $8.66 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,165,811
Previous 2,161,902
0.18%
Holding current value
$8.66 Million
Previous $7.31 Million
1.07%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VIGL
# of Institutions
54Shares Held
26.7MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$23.3 Million2.49% of portfolio
-
Northpond Ventures, LLC4.21MShares$16.9 Million40.32% of portfolio
-
Bvf Inc San Francisco, CA1.81MShares$7.25 Million0.19% of portfolio
-
Artal Group S.A. Luxembourg, N41.81MShares$7.24 Million0.33% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.73MShares$6.92 Million0.92% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $113M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...